(Sharecast News) - Moderna's Covid-19 vaccine candidate will not be ready by the 3 November presidential elections in the US, but it could be by the end of that month.
In an interview with the Financial Times, the chief executive of the biotechnology firm, one of the front-runners to develop a Covid-19 vaccine, also said that submission for approval under expedited emergency use authorisation would not be sought before 25 November - at the earliest.
He did not anticipate full-scale public distribution until spring 2021.
"I think a late [first quarter], early [second quarter] approval is a reasonable timeline, based on what we know from our vaccine," Stephane Bancel reportedly told the FT.
-- More to follow --